LivaNova PLC LIVN
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2015-10-19
Chart by TradingView
4/9
Piotroski F — financial health
0.72
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Valuation · market cap as of 2026-06-29
Market cap$4.6B
P / S3.3×
P / B3.8×
P / FCF26.4×
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $1.4B | $1.3B | $1.2B | $1.0B | $1.0B |
| Gross profit | $939.9M | $853.5M | $755.8M | $707.2M | $706.0M |
| Operating income | $199.4M | $129.1M | -$68.5M | -$76.8M | -$784,000 |
| Net income | -$242.5M | $63.2M | $17.5M | -$86.2M | -$135.8M |
| Operating cash flow | $254.3M | $183.0M | $74.9M | $69.9M | $102.5M |
| Free cash flow | $173.3M | $135.9M | $39.9M | $43.4M | $77.1M |
| Total assets | $2.6B | $2.5B | $2.4B | $2.3B | $2.2B |
| Total liabilities | $1.4B | $1.2B | $1.2B | $1.1B | $906.3M |
| Shareholders' equity | $1.2B | $1.3B | $1.3B | $1.2B | $1.3B |
| Ratios | |||||
| Gross margin | 67.7% | 68.1% | 65.5% | 69.2% | 68.2% |
| Operating margin | 14.4% | 10.3% | -5.9% | -7.5% | -0.1% |
| Net margin | -17.5% | 5.0% | 1.5% | -8.4% | -13.1% |
| FCF margin | 12.5% | 10.8% | 3.5% | 4.2% | 7.4% |
| Return on assets | -9.3% | 2.5% | 0.7% | -3.8% | -6.2% |
| Return on equity | -20.2% | 4.8% | 1.4% | -7.1% | -10.5% |
| Debt / equity | 0.31× | 0.47× | 0.46× | 0.43× | 0.01× |
| Current ratio | 1.36 | 2.87 | 2.95 | 2.98 | 0.97 |
| Revenue growth | 10.7% | 8.7% | 12.9% | -1.3% | 10.8% |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.72 (distress)
- Working capital / assets 0.113
- Retained earnings / assets -0.44
- EBIT / assets 0.077
- Equity / liabilities 0.853
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001639691 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.